Thomas Civik serves as Executive at Foundation Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Civik has executed 10 insider transactions totaling $410.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 28, 2026 involved selling 7,500 shares valued at $0.
Thomas Civik currently holds 206,186 shares of Foundation Medicine, Inc. (FMI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Civik has been a net buyer of FMI stock. They have purchased $410.6K and sold $0 worth of shares.
Thomas Civik's most recent insider trade was on Jan 28, 2026, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 31, 2022 | PYXS | $0 | Award | 66,831 | $N/A | Discretionary |
| Nov 18, 2021 | PYXS | $200.0K | Purchase | 15,700 | $12.74 | Discretionary |
| Nov 16, 2021 | RPTX | $210.6K | Purchase | 7,500 | $28.08 | Discretionary |
| Apr 16, 2021 | FPRX | $2.6M | Disposition | 68,971 | $38.00 | Discretionary |
| Apr 9, 2021 | FPRX | $420.7K | Payment | 11,088 | $37.94 | Discretionary |
| Apr 13, 2020 | FPRX | $0 | Award | 75,000 | $N/A | Discretionary |
| Jul 31, 2018 | FMI | $4.6M | Other | 33,421 | $137.00 | Discretionary |
| Jan 1, 2018 | FMI | $2.3M | Award | 33,421 | $68.20 | Discretionary |